2 Global Morphine Quarterly Market Size Analysis

• 2.1 Morphine Business Impact Assessment - COVID-19
  • 2.1.1 Global Morphine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
  • 2.1.2 Global Morphine Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Morphine Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 Global Morphine Quarterly Market Size by Manufacturers, 2019 VS 2020
• 3.2 Global Morphine Factory Price by Manufacturers
• 3.3 Location of Key Manufacturers Morphine Manufacturing Factories and Area Served
• 3.4 Date of Key Manufacturers Enter into Morphine Market
• 3.5 Key Manufacturers Morphine Product Offered
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Morphine Segments, By Type

• 4.1 Introduction
  • 1.4.1 Oral Tablets
  • 1.4.2 Injection
  • 1.4.3 Capsule
  • 1.4.4 Others
• 4.2 By Type, Global Morphine Market Size, 2019-2021
  • 4.2.1 By Type, Global Morphine Market Size by Type, 2020-2021
  • 4.2.2 By Type, Global Morphine Price, 2020-2021

5 Impact of Covid-19 on Morphine Segments, By Application

• 5.1 Overview
  • 5.5.1 Anesthesia
  • 5.5.2 Cough Suppressant
  • 5.5.3 Diarrhea Suppressant
• 5.2 By Application, Global Morphine Market Size, 2019-2021
  • 5.2.1 By Application, Global Morphine Market Size by Application, 2019-2021
  • 5.2.2 By Application, Global Morphine Price, 2020-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Mallinckrodt Pharmaceuticals
  • 7.1.1 Mallinckrodt Pharmaceuticals Business Overview
  • 7.1.2 Mallinckrodt Pharmaceuticals Morphine Quarterly Production and Revenue, 2020
  • 7.1.3 Mallinckrodt Pharmaceuticals Morphine Product Introduction
  • 7.1.4 Mallinckrodt Pharmaceuticals Response to COVID-19 and Related Developments
• 7.2 Alcaliber
  • 7.2.1 Alcaliber Business Overview
  • 7.2.2 Alcaliber Morphine Quarterly Production and Revenue, 2020
  • 7.2.3 Alcaliber Morphine Product Introduction
  • 7.2.4 Alcaliber Response to COVID-19 and Related Developments
• 7.3 Purdue Pharma
  • 7.3.1 Purdue Pharma Business Overview
  • 7.3.2 Purdue Pharma Morphine Quarterly Production and Revenue, 2020
  • 7.3.3 Purdue Pharma Morphine Product Introduction
  • 7.3.4 Purdue Pharma Response to COVID-19 and Related Developments
• 7.4 Sanofi Winthrop Industrie
  • 7.4.1 Sanofi Winthrop Industrie Business Overview
  • 7.4.2 Sanofi Winthrop Industrie Morphine Quarterly Production and Revenue, 2020
  • 7.4.3 Sanofi Winthrop Industrie Morphine Product Introduction
  • 7.4.4 Sanofi Winthrop Industrie Response to COVID-19 and Related Developments
• 7.5 Macfarlan Smith
  • 7.5.1 Macfarlan Smith Business Overview
  • 7.5.2 Macfarlan Smith Morphine Quarterly Production and Revenue, 2020
  • 7.5.3 Macfarlan Smith Morphine Product Introduction
  • 7.5.4 Macfarlan Smith Response to COVID-19 and Related Developments
• 7.6 Sun Pharmaceutical Industries
  • 7.6.1 Sun Pharmaceutical Industries Business Overview
  • 7.6.2 Sun Pharmaceutical Industries Morphine Quarterly Production and Revenue, 2020
  • 7.6.3 Sun Pharmaceutical Industries Morphine Product Introduction
  • 7.6.4 Sun Pharmaceutical Industries Response to COVID-19 and Related Developments
• 7.7 Qinghai Pharmaceutical
  • 7.7.1 Qinghai Pharmaceutical Business Overview
  • 7.7.2 Qinghai Pharmaceutical Morphine Quarterly Production and Revenue, 2020
  • 7.7.3 Qinghai Pharmaceutical Morphine Product Introduction
  • 7.7.4 Qinghai Pharmaceutical Response to COVID-19 and Related Developments
• 7.8 Northeast Pharmaceutical Group
  • 7.8.1 Northeast Pharmaceutical Group Business Overview
  • 7.8.2 Northeast Pharmaceutical Group Morphine Quarterly Production and Revenue, 2020
  • 7.8.3 Northeast Pharmaceutical Group Morphine Product Introduction
  • 7.8.4 Northeast Pharmaceutical Group Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

• 8.1 Morphine Supply Chain Analysis
  • 8.1.1 Morphine Supply Chain Analysis
  • 8.1.2 Covid-19 Impact on Morphine Supply Chain
• 8.2 Distribution Channels Analysis
  • 8.2.1 Morphine Distribution Channels
  • 8.2.2 Covid-19 Impact on Morphine Distribution Channels
  • 8.2.3 Morphine Distributors
• 8.3 Morphine Customers

9 Key Findings

10 Appendix

• 10.1 About Us

This report covers market size and forecasts of Morphine, including the following market information:
Global Morphine Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (Kiloton)
Global Morphine Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (Kiloton)
Global Morphine Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (Kiloton)
Global Morphine Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (Kiloton)

Key market players
Major competitors identified in this market include Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Sanofi Winthrop Industrie, Macfarlan Smith, Sun Pharmaceutical Industries, Qinghai Pharmaceutical, Northeast Pharmaceutical Group, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Oral Tablets
Injection
Capsule
Others

Based on the Application:
Anesthesia
Cough Suppressant
Diarrhea Suppressant